Pharmafile Logo

Medscape Oncology Launches Inaugural Medscape Fellows Program at ASCO 2024

- PMLiVE

Medscape Oncology is excited to announce the launch of the first-ever Medscape Fellows Program at the 2024 ASCO meeting in Chicago, Illinois. This groundbreaking program aims to nurture young oncology talent and advance outcomes through education.

“Today’s fellows represent the future of oncology. Our Medscape Oncology Fellows are poised to become leaders in cancer care, and we wanted to bring them together at oncology’s biggest event in the United States to show them the impact they can make. We’re looking forward to a weekend full of events and programs for them,” said Natasha McGrath, Executive Director, Medscape Education.

The Medscape Fellows Program will kick off with a welcome reception and feature a series of events throughout the weekend designed to inspire, educate, and connect fellows with leading experts in the field. By engaging in workshops, networking opportunities, symposia, and focus group sessions, fellows will gain valuable insights and skills to advance their careers and improve patient outcomes.

Medscape will also use insights from this program to help build new tools and programs designed to engage and elevate both fellows and young faculty. By placing education at the forefront, Medscape aims to advance clinical practice and improve patient outcomes.

For more information on the Medscape Fellows Program, please contact Natasha McGrath at NMcGrath@Medscape.net.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...

#ShortenTheJourney

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Why Sleep Health is the Missing Link in Women’s Wellness

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.